Nomura Holdings Inc. Takes Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Nomura Holdings Inc. bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 26,376 shares of the medical instruments supplier's stock, valued at approximately $501,000.

A number of other hedge funds have also recently bought and sold shares of the company. Treasurer of the State of North Carolina grew its holdings in DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock worth $1,686,000 after acquiring an additional 560 shares during the period. UMB Bank n.a. grew its holdings in DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after acquiring an additional 564 shares during the period. Blue Trust Inc. grew its holdings in DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier's stock worth $137,000 after acquiring an additional 707 shares during the period. Quarry LP grew its holdings in DENTSPLY SIRONA by 25.7% during the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after acquiring an additional 780 shares during the period. Finally, Federated Hermes Inc. grew its holdings in DENTSPLY SIRONA by 0.5% during the fourth quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock worth $3,213,000 after acquiring an additional 915 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. The trade was a 22.66% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.50% of the company's stock.

Analyst Ratings Changes

XRAY has been the topic of a number of research analyst reports. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a report on Tuesday, April 15th. Piper Sandler lowered their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. UBS Group dropped their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research note on Friday, May 9th. Finally, Wall Street Zen raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Eleven research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $20.36.

DENTSPLY SIRONA Stock Up 5.6%

NASDAQ XRAY traded up $0.87 during trading on Tuesday, reaching $16.34. 2,368,514 shares of the company's stock were exchanged, compared to its average volume of 2,966,347. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $28.25. The firm has a market capitalization of $3.26 billion, a PE ratio of -7.89, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company's fifty day simple moving average is $14.48 and its 200-day simple moving average is $17.06.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. During the same period last year, the company posted $0.42 EPS. The business's quarterly revenue was down 7.8% compared to the same quarter last year. Sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.92%. DENTSPLY SIRONA's payout ratio is presently -14.10%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.